Convulsions (Seizures) – Comprehensive Medical Guide

Overview

Convulsions, commonly referred to as seizures, are sudden, uncontrolled electrical disturbances in the brain that can cause a wide range of symptoms—from brief lapses of awareness to full‑body convulsive movements. They are a symptom rather than a disease, meaning they can arise from many underlying conditions.

Who is affected? Seizures can occur at any age, but the epidemiology differs by type:

• Overall, about 1 in 26 people (≈3.8 %) will develop epilepsy (recurrent unprovoked seizures) during their lifetime [1].
• Incidence peaks in early childhood (especially < 2 years) and again after age 65 [2].
• Both sexes are affected equally, though certain seizure‑triggering disorders (e.g., stroke) are more common in men.

While most seizures are isolated events, about 60 % of individuals who experience a first seizure will have another within five years if no treatment is started [3]. Prompt diagnosis and appropriate therapy dramatically reduce morbidity.

Symptoms

Seizure symptoms depend on the brain region involved and how much of it is affected. They are generally divided into focal (partial) and generalized categories.

Generalized seizures

• Absence (petit mal) seizures – brief staring spell, eyelid fluttering, subtle hand automatisms; lasts <10 seconds.
• Tonic‑clonic (grand mal) seizures – loss of consciousness, stiffening (tonic phase) followed by rhythmic jerking (clonic phase); may include tongue biting, incontinence, and post‑ictal confusion.
• Atonic seizures – sudden loss of muscle tone, causing the person to drop or fall.
• Myoclonic seizures – brief, shock‑like jerks of a limb or the whole body.
• Clonic seizures – rhythmic jerking movements without the initial stiffening.

Focal (partial) seizures

• Simple focal seizures – awareness is preserved; symptoms may include shaking of one limb, tingling, visual or auditory hallucinations, or a sudden sense of fear.
• Complex focal seizures – awareness is impaired; the person may stare, perform automatisms (e.g., lip smacking, picking at clothing), or appear confused.
• Focal seizures evolving to bilateral tonic‑clonic – start in one area and spread, eventually presenting like a generalized tonic‑clonic seizure.

Other associated features

• Pre‑ictal aura (often a sensory warning that a seizure is imminent)
• Post‑ictal fatigue, headache, or temporary weakness (Todd’s paralysis)
• Emotional changes – fear, anxiety, or euphoria
• Injury from falls or accidents during a convulsive seizure

Causes and Risk Factors

Seizures arise when neurons fire synchronously and excessively. Triggers can be structural, metabolic, infectious, genetic, or idiopathic.

Common causes

• Epilepsy – chronic disorder with recurrent unprovoked seizures; often idiopathic or due to subtle cortical malformations.
• Acute brain injury – traumatic brain injury, stroke, intracranial hemorrhage, or tumor [4].
• Metabolic disturbances – hypoglycemia, hyponatremia, hypermagnesemia, renal or hepatic failure.
• Infections – meningitis, encephalitis, cerebral malaria, HIV.
• Withdrawal – abrupt cessation of alcohol, benzodiazepines, or other sedatives.
• Fever – especially in children (febrile seizures).
• Genetic syndromes – e.g., Dravet syndrome, Lennox‑Gastaut syndrome.

Risk factors

• History of previous seizure or epilepsy
• Family history of epilepsy (genetic predisposition)
• Neonatal complications (asphyxia, intracranial hemorrhage)
• Chronic neurological diseases (multiple sclerosis, Alzheimer’s disease)
• Substance abuse (stimulants, cocaine)
• Sleep deprivation and extreme stress

Diagnosis

Because seizures are a clinical phenomenon, the diagnostic work‑up focuses on confirming the event, identifying the type, and uncovering an underlying cause.

Clinical evaluation

• Detailed medical history – description of the event, aura, triggers, previous episodes, medications, and family history.
• Physical and neurological examination – to detect focal deficits, skin lesions, or signs of infection.

Electrodiagnostic tests

• Electroencephalogram (EEG) – records brain’s electrical activity; interictal spikes, sharp waves, or seizure patterns help classify seizure type. Ambulatory or video‑EEG monitoring may capture events that occur infrequently.
• Magnetoencephalography (MEG) – used in pre‑surgical evaluation for refractory epilepsy.

Imaging studies

• Magnetic Resonance Imaging (MRI) – preferred modality for detecting structural lesions (tumors, malformations, scar tissue). Specialized epilepsy protocols (e.g., 3‑T MRI with epilepsy protocol) improve yield.
• Computed Tomography (CT) – rapid assessment in emergency settings (e.g., after trauma or suspected hemorrhage).

Laboratory tests

• Basic metabolic panel (glucose, electrolytes, renal/hepatic function)
• Serum toxicology if drug ingestion is suspected
• Lumbar puncture when infection is a concern

Special considerations

• Genetic testing – increasingly used for early‑onset epilepsies with suspected channelopathies.
• Neuropsychological testing – helps assess cognitive impact, especially for surgical candidates.

Treatment Options

Treatment aims to stop seizures, prevent recurrence, and address the underlying cause while minimizing side effects.

Acute management (seizure cessation)

• First‑line benzodiazepines – lorazepam 0.1 mg/kg IV (max 4 mg), diazepam 0.2 mg/kg IM/IV, or midazolam intranasal/rectal for out‑of‑hospital use.
• If seizures continue >5 min (status epilepticus), administer second‑line agents such as fosphenytoin, valproate, or levetiracetam.
• Intubation and continuous EEG monitoring may be required for refractory status epilepticus.

Long‑term seizure control

Choice of anti‑seizure medication (ASM) depends on seizure type, comorbidities, age, and potential drug interactions.

Medication	Typical indications	Key side effects
Levetiracetam	Broad spectrum – focal, generalized	Fatigue, irritability, mood changes
Lamotrigine	Focal, generalized tonic‑clonic	Rash (rare Stevens‑Johnson), dizziness
Carbamazepine	Focal seizures	Hyponatremia, sedation, drug interactions
Valproate	Generalized (absence, myoclonic)	Weight gain, hair loss, teratogenicity
Ethosuximide	Absence seizures	Gastro‑intestinal upset, fatigue

Therapeutic drug monitoring is recommended for agents with narrow therapeutic windows (e.g., phenytoin, valproate).

Surgical and device‑based therapies

• Resective epilepsy surgery – removal of a well‑localized seizure focus (e.g., hippocampal sclerosis).
• Laser interstitial thermal therapy (LITT) – minimally invasive ablation.
• Vagus nerve stimulator (VNS) – implanted device that delivers intermittent electrical pulses to reduce seizure frequency.
• Responsive neurostimulation (RNS) – detects abnormal activity and delivers targeted stimulation.
• Ketogenic diet – high‑fat, low‑carbohydrate diet effective for refractory pediatric epilepsy.

Lifestyle & adjunctive measures

• Avoid known triggers (sleep deprivation, alcohol bingeing, flashing lights for photosensitive epilepsy).
• Maintain a regular sleep schedule and stress‑reduction techniques.
• Educate family, coworkers, and school personnel about seizure first‑aid.

Living with Convulsions (Seizures)

Managing epilepsy is a lifelong partnership between patient, caregivers, and healthcare providers.

Medication adherence

• Take ASMs exactly as prescribed; use pillboxes or smartphone reminders.
• Never stop a medication abruptly without medical guidance; withdrawal can provoke seizures.

Safety precautions

• Bathing: Use a shower instead of a tub; sit while washing to avoid drowning if a seizure occurs.
• Driving: Most jurisdictions require a seizure‑free period (often 6 months) and physician clearance before obtaining a license.
• Workplace: Request reasonable accommodations (e.g., additional breaks, seizure‑alert dogs).
• Exercise: Moderate activities are safe; avoid high‑risk sports (e.g., rock climbing without supervision) unless seizure‑free.

Psychosocial support

• Connect with epilepsy support groups (Epilepsy Foundation, online forums).
• Address comorbid depression or anxiety—common in up to 30 % of patients [5].
• Consider cognitive rehabilitation if memory or attention problems arise.

Monitoring & follow‑up

• Schedule regular neurology visits (every 3–12 months) to assess seizure control and medication side effects.
• Keep a seizure diary: date, time, duration, aura, trigger, and post‑ictal symptoms.
• Update vaccination status; influenza and COVID‑19 infections can lower seizure threshold.

Prevention

While not all seizures are preventable, risk reduction strategies can lower incidence, especially for provoked (acute) seizures.

• Control chronic diseases—manage hypertension, diabetes, and hyperlipidemia to reduce stroke risk.
• Avoid head trauma—use helmets while cycling, motorcycling, or participating in contact sports.
• Limit alcohol and substance use—binge drinking and stimulants can precipitate seizures.
• Adhere to medication regimens for conditions such as epilepsy, psychiatric disorders, and sleep apnea.
• Maintain adequate sleep—7–9 hours for adults; consistent bedtime routine.
• In infants, follow pediatric fever‑management guidelines to reduce febrile seizure risk (rectal acetaminophen or ibuprofen for temperatures >38.5 °C).

Complications

If seizures are uncontrolled or left untreated, several serious complications may arise:

• Status epilepticus – a seizure lasting ≥5 minutes or repeated seizures without regaining consciousness; can cause brain injury, respiratory failure, and death.
• Physical injuries – fractures, head trauma, burns, or drowning.
• Cognitive decline – frequent seizures, especially during early brain development, can impair learning and memory.
• Psychiatric comorbidities – depression, anxiety, and increased risk of suicide (up to 5 % lifetime prevalence) [6].
• Reproductive issues – certain ASMs (e.g., valproate) are teratogenic; women of childbearing age need counseling.
• Social consequences – stigma, loss of employment, driving restrictions.

When to Seek Emergency Care

---

References

1. Centers for Disease Control and Prevention. Epilepsy Data and Statistics. 2023. https://www.cdc.gov/epilepsy/about/epidemiology.html
2. Thurman DJ, et al. Epidemiology of the lifetime prevalence of epilepsy. Seizure. 2022;102:69‑78.
3. Wiebe S, et al. Predictors of seizure recurrence after a first unprovoked seizure. Neurology. 2021;96(12):e1654‑e1663.
4. Mayo Clinic. Seizure causes and risk factors. Updated 2024. https://www.mayoclinic.org/diseases-conditions/epilepsy/symptoms-causes/syc-20350093
5. Hesdorffer DC. Depression in epilepsy: prevalence, impact, and treatment challenges. Curr Psychiatry Rep. 2020;22(12):69.
6. World Health Organization. Epilepsy fact sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/epilepsy